However, no significant association was found between ALT levels and cognitive impairment risk within the range of 17 to 40 (OR: 1.00; 95% CI: 0.98–1.02) or beyond the inflection point of 40 (OR: 0.96; 95% CI: 0.91–1.01). The gene discussed is GPT; the disease is Cognitive impairment.